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Abstract
Rapid diagnosis and immediate infection control precautions are
cornerstones in the prevention of norovirus outbreaks. However,
faecal sampling for norovirus PCR—the standard of care—is time
consuming. From 2009 to 2011, parallel faecal and rectal swab
samples were consecutively obtained from patients with acute
gastroenteritis presenting at our emergency department. In total,
109 complete sample pairs of 108 patients were analysed by
specific norovirus real-time PCR. The sensitivity of real-time PCR
was 97.3% (36/37) for both sampling methods. A rectal swab is a
reasonable option for detection of norovirus by real-time PCR, if a
stool specimen is not readily available.
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Introduction
Noroviruses (NoVs) are the leading cause of epidemic
gastroenteritis [1]. Although NoV gastroenteritis is generally
mild and short in duration in immuncompetent individuals,
rapid and accurate detection of NoV is key to the prevention
of the secondary spread of this highly transmissible virus within
hospital wards and other closed settings such as long-term
care facilities [2–4]. According to CDC guidelines, faecal
samples are preferred over rectal swabs for detection of NoV
by real-time PCR because of the higher quantity of virus
present in whole stools [5]. However, collection of faecal
samples is a time consuming and impractical procedure in daily
clinical routine, which potentially delays subsequent infection
control measures for NoV gastroenteritis. Patients with
diarrhoea commonly flush the toilet before healthcare work-
ers can take a stool sample. We therefore aimed to compare
the diagnostic performance of rectal swab and faecal samples
for detection of NoV by real-time PCR.
This was a prospective observational study performed at
the University Hospital Basel, a 855-bed tertiary-care hospital
in Switzerland with >33 000 admissions per year. From March
2009 to December 2011, parallel faecal and rectal swab
samples were consecutively obtained from all patients who
presented at our emergency department with symptoms and
signs that suggest NoV. Only complete pairs of samples—a
faecal and a rectal swab sample—were included in the study.
Basic demographic, clinical, laboratory and outcome parame-
ters were retrieved from written and electronic medical
records. The local ethics committee approved the study as
part of a continuing quality improvement programme.
Rectal swab samples were collected in a standardized way
with a sterile flocked swab (COPAN ESwabTM, Copan Diag-
nostics Inc., Murrieta, CA, USA). Around 1–2 mL of whole
stool was sampled in a sterile tube. Rectal swabs and faecal
samples were directly sent to an external microbiological
laboratory (Viollier AG, Basel, Switzerland) for NoV detection
by real-time PCR. In brief, RNA was extracted from 200 lL of
diluted stool/transport medium using NucliSENS easyMAG
(bioMerieux Inc., Durham, NC, USA) according to the
manufacturer’s instructions. Real-time PCR was performed
on 5 lL of sample RNA, analysed with the validated AnDia-
Tec Norovirus real-time reverse transcriptase PCR Kit [6]
(AnDiaTec GmbH & Co. KG, Kornwestheim, Germany).
We performed a matched analysis using the exact McNe-
mar’s test. We analysed all data with the use of SPSS 22
software (IBM Inc., Chicago, IL, USA). All p values are
two-sided.
In total, 109 complete sample pairs of 108 patients were
analysed by NoV real-time PCR; one patient had a recurrent
episode of gastroenteritis 7 months after the initial episode.
Thirty-five sample pairs were positive in both the rectal swab
and faecal sample; whereas one pair was positive in the faecal
sample only and one pair in the rectal swab only (Table 1).
Seventy-two sample pairs were both negative in the rectal
swab and faecal sample. There was no significant difference in
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the proportion of NoV real-time PCR positive and negative
results between the two sampling methods in matched analysis
(p 1.000; Table 1). The sensitivity was 97.3% (36/37) for both
samples, with a positive NoV real-time PCR in either sample
type considered the reference standard, as previously
described for comparison of sampling methods [7,8].
The mean age was 56.2 years (95% confidence interval (CI),
52.0–60.4); 66.1% of patients were subsequently hospitalized
and one patient with a negative NoV real-time PCR died.
Cases of epidemic gastroenteritis and vomitus were more
common in patients with positive faecal NoV real-time PCR
compared with patients with negative faecal NoV real-time
PCR (28.6% vs. 8.2%, p 0.005; and 91.7% vs. 75.3%, p 0.018)
(Table 2).
In 80 patients, the timeline of the diagnostic cascade was
documented (mean total time to PCR result, 26.4 h; 95% CI,
23.4–29.4). In these patients, mean time from hospitalization
to collection of both faecal and rectal swab samples was 6.2 h
(95% CI, 4.4–7.9); mean time from sample collection to arrival
in the laboratory was 12.2 h (95% CI, 9.3–15.0) and mean time
from sample arrival to reporting of the final results was 8.0 h
(95% CI, 6.9–9.2).
We showed equal sensitivity of both rectal swab and faecal
sample for detection of NoV by specific real-time PCR in
adults. Our finding stands in contrast to the CDC recom-
mendation, advocating the use of whole stool samples for the
diagnosis of NoV gastroenteritis by real-time PCR [5].
A study performed in children aged 0.5–4.99 years from
Rwanda showed no significant difference in detection rates of
NoV and other viruses in a multiplex PCR for both sample
types (NoV faeces sensitivity, 85%; NoV rectal swab sensitivity,
78%) [9]. Nevertheless, the rectal swab samples contained an
up to ten times lower amount of bacterial and viral pathogens
TABLE 1. Matched comparison of faecal specimen vs. rectal
swab specimen for the detection of norovirus by real-time
PCR
Faecal sample
positive
Faecal sample
negative p value
Rectal swab positive 35 1 1.000
Rectal swab negative 1 72 1.000
Data are n, unless stated otherwise. n indicates the number of paired faecal/rectal
specimens analysed by real-time PCR (n = 109).
TABLE 2. Comparison of demographic, clinical and laboratory characteristics of patients with norovirus real-time PCR positive
and PCR negative gastroenteritis (based on faecal sample only)
Variable
Patients with NoV PCR-
positive gastroenteritisa
n = 36
Patients with NoV PCR-
negative gastroenteritis
n = 73 p value
Male gender 14 (38.9) 25 (34.2) 0.643
Mean age, years (95% CI) 51.2 (43.3–59.1) 58.6 (53.7–63.6) 0.113
Nationality
Swiss 20 (55.6) 53 (72.6) 0.075
Northern European 7 (19.4) 8 (11.0) 0.247
Southern European 7 (19.4) 9 (12.3) 0.324
Other 2 (5.6) 3 (4.1) 1.000
Immunosuppressionb 4 (11.1) 10 (13.9) 0.774
Epidemic casesc 10 (28.6) 6 (8.2) 0.005
Hospitalizationb 17 (47.2) 55 (76.4) 0.004
ICU admission 1 (2.8) 3 (4.1) 1.000
In-hospital death 0 (0.0) 1 (1.4) 1.000
Laboratory characteristicsd
Mean leucocyte count, G/L (95% CI) 12.5 (11.2–13.8) 11.6 (10.6–12.7) 0.288
Mean CRP, mg/L (95% CI) 33.0 (9.2–56.7) 56.2 (32.6–79.8) 0.166
Clinical symptoms
Acute onset of symptomse 33 (91.7) 65 (89.0) 1.000
Diarrhoeaf 35 (97.2) 60 (82.2) 0.056
Nausea 29 (80.6) 55 (75.3) 0.348
Vomitusf 33 (91.7) 55 (75.3) 0.018
Blood in stoolf 1 (2.8) 6 (8.2) 0.666
Abdominal pain 20 (55.6) 45 (61.6) 0.786
Clinical signsg
Mean systolic blood pressure, mmHg (95% CI) 123.9 (116.6–131.2) 126.4 (120.7–132.2) 0.581
Mean diastolic blood pressure, mmHg (95% CI) 71.9 (66.6–77.2) 72.5 (68.9–76.1) 0.862
Mean heart rate, bpm (95% CI) 89.4 (81.8–97.1) 89.4 (83.9–94.9) 1.000
Mean tympanic temperature, °C (95% CI) 37.4 (37.1–37.8) 37.2 (37.0–37.4) 0.174
Data are n (%), unless stated otherwise. n indicates the number of patients.
bpm, beats per minute; CI, confidence interval; CRP, C-reactive protein; NoV, norovirus; PCR, polymerase chain reaction.
aNoV PCR positive faecal sample.
bMissing information for one patient with faecal NoV PCR-negative gastroenteritis (n = 72).
cIn epidemic cases, at least one additional case of acute gastroenteritis in the direct patient’s environment had to be noted. Missing information for one patient with faecal NoV
PCR-positive gastroenteritis (n = 35).
dMeasured on day of hospital admission.
eOnset of symptoms that suggest gastroenteritis within 24 h.
fReported by patient.
gOn day of hospital admission. Missing information for one patient (n = 108).
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compared with faecal samples as measured by real-time
quantitative PCR [9]. Gustavsson et al. compared 69 sample
pairs obtained from patients hospitalized in a Swedish univer-
sity hospital developing acute gastroenteritis: NoV detection
rate in multiplex real-time PCR was for both sample types
100% (27/27) [8]. The results of these two studies correspond
well with our results. However, a retrospective study from
West Virginia showed rectal swab samples to be less sensitive
than faecal samples for the detection of NoV by enzyme
immunoassay (43% of faecal samples and 35% of rectal swab
samples were positive; p <0.001) [10].
We acknowledge several study limitations. First, we did not
quantify NoV stool concentration by means of real-time PCR,
which has been suggested to increase specificity of NoV testing
[11]. Second, we were unable to reliably measure the time
from hospital admission to rectal swab and faecal sampling
separately. However, the bottleneck for sampling was most
likely the stool specimen, because rectal swabs are obtained by
the emergency nurses, who are trained to get the samples as
fast as possible.
In conclusion, rectal swab and faecal samples have equal
sensitivity for detection of NoV by real-time PCR. Rectal swab
sampling is a reasonable approach to expedite sampling, if a
stool sample is not readily available. Rapid diagnosis, in
particular in a busy emergency department, is crucial to
prevent spread of nosocomial NoV.
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